Eagle Pharmaceuticals
EGRX
#10347
Rank
HK$70.61 M
Marketcap
HK$5.45
Share price
0.00%
Change (1 day)
-17.60%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$70.61 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of HK$70.61 Million. This makes Eagle Pharmaceuticals the world's 10347th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$70.61 M27.62%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
HK$70.61 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$3.787 T 5,363,386.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$760.69 B 1,077,191.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$1.974 T 2,795,559.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
HK$254.18 B 359,866.14%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$1.382 T 1,958,274.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.050 T 9,984,723.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$826.44 B 1,170,304.01%๐Ÿ‡บ๐Ÿ‡ธ USA